Innovative Medicine Initiatives (IMI): http://www.imi.europa.eu/content/home

European Federation of Pharmaceutical Industries and Associations (efpia): http://www.efpia.eu/ 

European Commission (EC): http://ec.europa.eu/index_en.htm

Horizon 2020: http://ec.europa.eu/programmes/horizon2020/

Factsheet on EU response to Ebola: http://europa.eu/rapid/press-release_MEMO-14-599_en.htm

Ebola coordination site: http://europa.eu/newsroom/highlights/special-coverage/ebola/index_en.htm

WHO factsheet on Ebola: http://www.who.int/mediacentre/factsheets/fs103/en/
WHO statistics on the current outbreak: http://www.who.int/csr/disease/ebola/situation-reports/en/

 

News

  • 13 November 2016

    The joint EBOVAC1 and EBOVAC2 annual meeting took place in Windsor, UK from 14-16 November 2016.

  • 22 April 2016

    EBOVAC1 has published their first report on Phase 1 data in the April 19th 2016 issue of JAMA

    Press release and more information

  • 04 April 2016

    The first subject was vaccinated on 30 March 2016 at the University of Nairobi, Kenya

  • 29 March 2016

    The 1st EBOVAC2 Newsletter is available!

  • 29 February 2016

    The first subject was randomized on 10 December 2016 at Makerere University in Uganda.

  • 29 February 2016

    The first subject was randomized at CHU Treichville in Côte d'Ivoire on 26 February 2016.

More news
  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research